(Q46669368)

24 December 2017

title

Withdrawal-associated changes in peripheral nitrogen oxides and striatal cyclic GMP after chronic haloperidol treatment (English)

1 reference

24 December 2017

1 reference

1 reference

1

1 reference

24 December 2017

author name string

Bester A

series ordinal

2

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

24 December 2017

Behavioural Brain Research

published in

1 reference

24 December 2017

volume

111

1 reference

24 December 2017

issue

1-2

1 reference

24 December 2017

page(s)

203-211

1 reference

24 December 2017

Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboon

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Oxidative stress-resistant cells are protected against haloperidol toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

The cross-talk between nitric oxide and Ca2+: a story with a complex past and a promising future

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Chronic haloperidol treatment impairs glutamate transport in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Methylene blue adjuvant therapy of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Anxiolytic and antidepressant properties of methylene blue in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

How cytotoxic is nitric oxide?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Emergence of oral and locomotor activity in chronic haloperidol-treated rats following cortical N-methyl-D-aspartate stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Modulation of In Vivo Striatal Transmitter Release by Nitric Oxide and Cyclic GMP

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Affective Disorders and Nitric Oxide: A Role in Pathways to Relapse and Refractoriness?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Evidence that lithium induces a glutamatergic: nitric oxide-mediated response in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Blood nitrates and infantile methemoglobinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Inhibition of neuronal nitric oxide synthase by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Oxidative stress and the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Persistence of haloperidol in human brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

The effect of exhaustive exercise on the antioxidant enzyme system in skeletal muscle from calcium-deficient rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

The subsensitivity of striatal glutamate receptors induced by chronic haloperidol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Glutamate in CNS disorders as a target for drug development: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Antioxidant effects of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

Reduced level of plasma antioxidant uric acid in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

In vivo analysis of hydrogen peroxide and lipid radicals in the striatum of rats under long-term administration of a neuroleptic.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900156-X

7 January 2021

10.1016/S0166-4328(00)00156-X

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017